Skip to content

NU SKIN ENTERPRISES, INC.

NUS · XNYS

CIK 1021561fmd_0V087ZEG5Y1JSRW8D3CR0EJ9KBWholesale Trade · Wholesale-Drugs, Proprietaries & Druggists' SundriesTemplate: Standard

Coverage: Jan 01, 2008 to Sep 30, 2026, 71 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues2,2082,2792,6792,4202,5822,6962,2261,9691,7321,485
Cost of revenue500502634581658675631612550454
Gross profit1,7071,7772,0451,8391,9242,0201,5951,3571,1821,031
Research and development24222330232723231311
Total operating expenses1,4761,5031,8041,5721,6661,7861,4841,3091,333966
Operating income23127424126725823411148(152)66
Interest expense16222219131113262614
Other non-operating income (expense)(18)(9)(21)(12)(1)(2)(8)43(32)
Income before taxes2132662202552562328927(175)196
Income tax expense7013698826585(16)18(28)36
Net income from continuing operations1431291221741911471059(147)160
Net income1431291221741911471059(147)160
NU SKIN ENTERPRISES, INC. (NUS) financial statements · FinancialMD